Aurion Biotech, Inc. plans $100M IPO for corneal disease treatments, limited competition, Phase 1/2 trials underway with ...

Kala Pharmaceuticals Inc (NASDAQ:KALA)., a micro-cap biotech company valued at $40.13 million, has seen its stock reach a 52-week high, hitting an impressive $8.81. This peak reflects a significant ...

Purpose: To investigate the prognostic factors responsible for the progression of visual field defects (VFDs ... (IOP), IOP variability, central corneal thickness, and disc hemorrhage) were ...

On the left eye, the patient had conjunctival congestion and hyperemia, a central 2- × 2-mm corneal epithelial defect with deep stromal infiltration, endothelial plaque, moderate anterior chamber ...

Investigators recommend a dose of 0.2 mg/mL losartan 6 times per day for patients with a current corneal epithelial defect. Topical losartan for the treatment of scarring corneal fibrosis mediated by ...

A new bridge built as part of a project to widen a section of the A1 has been found to have defects. The Allerdene Bridge, in Gateshead, was replaced by a new structure that opened in September ...

A frequently updated review of the latest announcements and approvals from the FDA concerning ophthalmology. When in the hands of a skilled clinician, modern medical devices and pharmaceuticals can ...

SpectX, TNO, and partners GE Vernova and LM Wind Power, will start a 2-years project to detect sub-surface defects in wind turbine blades by drone X-ray inspection. The findings will be integrated ...

This is the opposite of what happens in crystals, whose ordered structure facilitates their mathematical description, as well as the identification of those "defects," which practically control ...

Fresh defects have been uncovered on one of Scotland’s ‘fiasco’ ferries almost on the eve of it finally entering service. The Glen Sannox will begin carrying passengers on Monday ...